XML 61 R40.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation Level 3 (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] The fair values of our stock options are calculated using the following weighted average assumptions, based on the methods described above:
Years Ended December 31,
Assumptions202520242023
Dividend yield1.7%1.8%1.6%
Expected volatility25.4%25.7%25.4%
Risk-free interest rate4.3%4.3%4.0%
Expected holding period (years)5.04.84.5
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
The following table summarizes certain information with respect to stock option and restricted share compensation included in our Consolidated Statement of Operations:
Years Ended December 31,
 202520242023
 (In thousands)
Pretax employee share-based compensation expense included in net income$15,923 $17,163 $15,423 
Pretax director share-based compensation expense included in net income$1,710 $1,620 $1,620 
Total pretax share-based compensation expense included in net income$17,633 $18,783 $17,043 
Income tax benefit related to share-based compensation included in net income$4,459 $4,358 $4,224 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
The following table sets forth stock option activity for the year ended December 31, 2025 (shares reported in whole numbers):
OptionsWeighted-Average
Exercise Price
Outstanding at December 31, 2024
3,643,548 $53.00 
Granted327,963 $78.57 
Exercised(704,448)$41.74 
Outstanding at December 31, 2025
3,267,063 $57.99 
Exercisable at December 31, 2025
2,589,716 $53.75 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
Set forth below is certain information related to stock options outstanding and exercisable at December 31, 2025 (shares reported in whole numbers):
 Options OutstandingOptions Exercisable
Range of Exercise Price
Number
Outstanding at
December 31, 2025
Weighted-Average Remaining Contractual Life
(in years)		Weighted-
Average Exercise Price
Number
Exercisable at
December 31, 2025
Weighted-
Average Exercise Price
$35.01 — 45.00467,588 1.0$42.01 467,588 $42.01 
$45.01 — 55.001,199,319 2.6$50.27 1,199,319 $50.27 
$55.01 — 65.00527,703 4.1$59.76 527,703 $59.76 
$65.01 — 75.00744,490 5.6$70.16 395,106 $70.21 
$75.01 — 85.00327,963 7.1$78.57 — $— 
$0.00 — 85.003,267,063 3.8$57.99 2,589,716 $53.75 
Other Information Pertaining to Stock Option Activity [Table Text Block]
Other information pertaining to stock options was as follows (in thousands, except weighted-average grant date fair value):
Years Ended December 31,
202520242023
Weighted average grant-date fair value of stock options granted$20.04 $17.28 $16.86 
Total fair value of stock options vested$5,720 $6,485 $6,059 
Total intrinsic value of stock options exercised$27,855 $70,019 $37,115 
Cash received from the exercise of stock options
$29,401 $56,683 $24,181 
Recognized compensation expense
$6,076 $6,701 $5,929 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Restricted share award activity was as follows (share awards reported in whole numbers):
Restricted
Share Awards		Weighted-Average
Grant-Date
Fair Value
Nonvested restricted share awards at December 31, 2024
174,989 $68.41 
Granted85,627 $78.57 
Vested(86,841)$66.70 
Nonvested restricted share awards at December 31, 2025
173,775 $74.27 
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Restricted
Share Units		Weighted-Average
Grant-Date
Fair Value
Nonvested restricted share units at December 31, 2024
103,954 $68.42 
Granted54,344 $78.57 
Vested(51,573)$66.73 
Forfeited and other(3,940)$74.28 
Nonvested restricted share units at December 31, 2025
102,785 $74.41